|
|
 |
Sir John Chisholm Chairman |
|
 |
|
|
Sir John became the Chairman of QinetiQ in 2005, after transforming the company in his time as its Chief Executive. He is widely credited with turning the organisation from a collection of research laboratories into a successful commercial business which floated on the London Stock Exchange in February 2006. A Cambridge graduate, Sir John’s career took flight when he formed CAP Scientific Ltd, which grew rapidly to become a core part of the CAP Group plc. He is the immediate past president of the IET and holds a number of Fellowships, including the Royal Academy of Engineering, and became Chairman of the Medical Research Council in October 2006. He was knighted in 1999. |
|
 |
|
|
|
 |
|
|
 |
Graham Love Chief Executive Officer |
|
 |
|
|
Graham is a graduate of Cambridge University, and a chartered accountant. In the late Eighties he was part of the senior management team that made Shandwick plc the world's number one PR Group through a major acquisition programme involving the purchase of over 30 public relations agencies worldwide.
In 1992, Graham joined the UK Government's Defence Research Agency as Finance Director and continued in the role when the agency expanded into DERA.
He was appointed Managing Director of the newly formed support services division (DSSD) in 1995. Two years later, he led the successful buy-out of DSSD from DERA to form Comax Secure Business Services Ltd. He subsequently led the team which negotiated the sale of Comax to Amey plc.
In 2001, Graham rejoined DERA as Chief Financial Officer subsequently playing a key role in the formation of QinetiQ and the sale of a controlling interest to The Carlyle Group.
In 2003 he became CEO of QinetiQ North America, and over the next two years led the acquisition of 4 US companies to create an important platform for QinetiQ in the US defence and security markets.
In 2005 Graham became Group CEO, working closely with the Chairman to lead QinetiQ through its successful IPO on the London Stock Exchange in early 2006. |
|
 |
|
|
|
 |
|
|
 |
Doug Webb Chief Financial Officer |
|
 |
|
|
Doug joined QinetiQ in 2003 as Group Financial Controller with responsibility for all aspects of the Group's finances including tax, treasury and insurance. He spent the previous 8 years with Logica (now LogicaCMG), latterly as Finance Director, Continental Europe and for 6 years in Logica's US subsidiary variously holding the roles of Chief Financial Officer, EVP Telecoms Division and Chief Operating Officer.
Prior to Logica, he spent 12 years in Audit and Business Advisory Services roles with Price Waterhouse in the UK, Canada and Sweden. Doug took a leave of absence in 2000/2001 to take part in the BT Global Challenge round the world yacht race as a watch leader and helmsman on Logica. Doug has a degree in Geography and Management Sciences from Cambridge and is a Fellow of the Institute of Chartered Accountants. |
|
 |
|
|
|
 |
|
|
 |
Sir David Lees Senior non-executive Director and Deputy Chairman Chairman of the nominations committee and the compliance committee.
|
|
 |
|
|
Sir David is currently chairman of Tate & Lyle plc and non-executive joint deputy chairman of Brambles Industries plc and Brambles Industries Limited. He has been a member of the UK Panel of Takeovers and Mergers since June 2001.
Sir David has had a distinguished career in British industry. He joined GKN plc in 1970 as an accountant and became group finance director in 1982. He was appointed group managing director in 1987, and chairman and chief executive in 1988 before becoming non-executive chairman in 1997 until his retirement in May 2004.
Other notable roles have included being a member of the National Defence Industries Council between 1995 to 2004; chairman of Courtaulds plc from July 1996 to Sept 1998; a non executive director of the Bank of England between March 1991 and May 1999; and chairman of the CBI Economic Affairs Committee from 1988 until mid 1994 as well as being a member of the CBI President's Committee from 1988 to 1996.
Sir David is currently a non executive director of the Royal Opera House, Covent Garden and chairman of the governing body of Shrewsbury School.
Sir David was appointed a Knight Bachelor in the Queen's birthday honour list in July 1991. In July 1996 he received the Officer's Cross of the Order of Merit of the German Federal Republic and in 1999 received the ICAEW Award for Outstanding Achievement. Sir David is a fellow of The Institute of Chartered Accountants in England and Wales. |
|
 |
|
|
|
 |
|
|
 |
Colin Balmer Non-executive Director |
|
 |
|
|
Colin has been MD of the Cabinet Office since 2003. Previously, Colin was Finance Director to the MOD, with responsibility for the vesting of QinetiQ and the subsequent PPP Transaction with Carlyle. He has extensive experience across the MOD including periods as Private Secretary to two Ministers for Defence Procurement, a secondment to the UK Delegation to NATO and as Minister for Defence Materiel in Washington. Colin was formerly a member of the independent Financial Reporting Advisory Board and the Advisory Council of Partnerships UK and is currently a member of the Foreign and Commonwealth Office's Audit and Risk Committee. |
|
 |
|
|
|
 |
|
|
 |
Noreen Doyle Non-executive Director |
|
 |
|
|
Until August 2005 Noreen Doyle was first vice president of the European Bank for Reconstruction and Development (EBRD). As head of banking she was responsible for the EBRD's £14 billion investments promoting the development of market economies across Eastern Europe and the former Soviet Union.
Ms Doyle is also a member of the Board of Directors of the Credit Suisse Group, the global financial services company headquartered in Zurich.
Noreen Doyle, a US and Irish citizen, holds a maths degree from the College of Mount Saint Vincent in New York, and an MBA from the Amos Tuck School, Dartmouth College, New Hampshire. |
|
 |
|
|
|
 |
|
|
 |
Dr Peter Fellner Non-executive Director Chairman of the remuneration committee |
|
 |
|
|
Peter Fellner has enjoyed a distinguished career in the pharmaceutical and biotech industries. This includes roles as Chief Executive of Roche UK, and as Chief Executive Officer and subsequently Chairman of Celltech Group plc. He is currently Chairman of Vernalis plc, and of two other biotechnology companies, and a member of the Medical Research Council. |
|
 |
|
|
|
 |
|
|
 |
Nick Luff Non-executive Director Chairman of the audit committee |
|
 |
|
|
Nick is a Non-executive director of QinetiQ and chairs the Audit Committee.
Nick was appointed Chief Financial Officer of Centrica plc in February 2007, having previously served as CFO of the P&O Group. He trained as a chartered accountant with KPMG and is a member of the Institute of Chartered Accountants in England and Wales. |
|
 |
|
|
|
 |
|
|
 |
Admiral Ed Giambastiani Non-executive Director |
|
 |
|
|
Between 2005 and 2007 Admiral Giambastiani was the second highest ranking military officer in the United States, serving as the seventh Vice Chairman of the Joint Chiefs of Staff.
In addition to his appointment as Vice Chairman of the Joint Chiefs of Staff, Admiral Giambastiani's distinguished naval career included assignments as Special Assistant to the CIA's Deputy Director for Intelligence, Senior Military Assistant to the US Defense Secretary and Commander, US Joint Forces Command. He also served as NATO's first Supreme Allied Commander Transformation where he led the transformation of the military alliance. Admiral Giambastiani currently serves as the non-executive chairman of the board of directors for Alenia North America, Inc. and as a non-executive director of SRA International, Inc. |
|
 |
|
|
|
 |
|
|